Wall Street Ratings Review on Nano Dimension Ltd. (NASDAQ:NNDM) & OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED)

Equity Research firms currently have a positive stance on shares of Nano Dimension Ltd. (NASDAQ:NNDM). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.50. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $12.50 on a short term basis.

At the time of writing, the stock was trading at $4.55. This represents a change from most recent open price of 5.81%. In terms of performance, year to date, the stock is -23.53%. The monthly stock performance comes in at -23.14%. For the quarter, shares are performing at -26.97%. Weekly performance analysis shows the equity at -13.00%.

In taking a look at technical levels, shares are trading -22.53% away from the 50 day simple moving average and -26.97% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -49.16% away from it’s 52- week high and 9.11% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Nano Dimension Ltd.’s RSI stands at 31.09. In looking at volatility levels, the shares saw weekly volatility of 7.33% and 3.87% over the past month.

Sell-side analysts are offering a consensus “Buy” rating on shares of OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 2.40.  Based on a recent trade, the shares are hovering around $3.88 which, according to analysts, yield significant upside potential to the $6.13 consensus target price.

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) shares typically trade an average volume of 370.56 and institutions hold 89.40% of the total shares.  


We see here that the stock is 8.61% away from the 20-Day Simple Moving Average.  Their 50-Day Simple Moving Average is a difference of 9.69% from current levels.  Further back, their 200-Day Simple Moving Average is -40.93% difference from today’s price.  Currently, the stock is -8.06% from its 50-Day High and 33.33% from the 50-day low. 

OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED)‘s stock has performed at -49.68%.  Breaking that down further, it has performed 0.52% for the week, 14.45% for the month, 11.17% over the last quarter, -53.08% for the past half-year and -66.95% for this last year. 

Leave a Comment